Search

Tan, Kemin, Mark Duquette, Andrzej Joachimiak, and Jack Lawler. 2009. “The Crystal Structure of the Signature Domain of Cartilage Oligomeric Matrix Protein: Implications for Collagen, Glycosaminoglycan and Integrin Binding.”. FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology 23 (8): 2490-501.

Sun, Jingfang, Benjamin D Hopkins, Kaoru Tsujikawa, Carole Perruzzi, Irit Adini, Robert Swerlick, Paul Bornstein, Jack Lawler, and Laura E Benjamin. 2009. “Thrombospondin-1 Modulates VEGF-A-Mediated Akt Signaling and Capillary Survival in the Developing Retina.”. American Journal of Physiology. Heart and Circulatory Physiology 296 (5): 1344-51.

Posey, Karen L, Kurt Hankenson, Alka C Veerisetty, Paul Bornstein, Jack Lawler, and Jacqueline T Hecht. 2008. “Skeletal Abnormalities in Mice Lacking Extracellular Matrix Proteins, Thrombospondin-1, Thrombospondin-3, Thrombospondin-5, and Type IX Collagen.”. The American Journal of Pathology 172 (6): 1664-74.

Kazerounian, S, K O Yee, and J Lawler. 2008. “Thrombospondins in Cancer.”. Cellular and Molecular Life Sciences : CMLS 65 (5): 700-12.

Daniel, Christoph, Kathrin Schaub, Kerstin Amann, Jack Lawler, and Christian Hugo. 2007. “Thrombospondin-1 Is an Endogenous Activator of TGF-Beta in Experimental Diabetic Nephropathy in Vivo.”. Diabetes 56 (12): 2982-9.

Zhang, Xuefeng, Caitlin Connolly, Mark Duquette, Jack Lawler, and Sareh Parangi. 2007. “Continuous Administration of the Three Thrombospondin-1 Type 1 Repeats Recombinant Protein Improves the Potency of Therapy in an Orthotopic Human Pancreatic Cancer Model.”. Cancer Letters 247 (1): 143-9.

Tan, Kemin, Mark Duquette, Jin-huan Liu, Rongguang Zhang, Andrzej Joachimiak, Jia-huai Wang, and Jack Lawler. 2006. “The Structures of the Thrombospondin-1 N-Terminal Domain and Its Complex With a Synthetic Pentameric Heparin.”. Structure (London, England : 1993) 14 (1): 33-42.

Zhang, Xuefeng, Eric Galardi, Mark Duquette, Jack Lawler, and Sareh Parangi. 2005. “Antiangiogenic Treatment With Three Thrombospondin-1 Type 1 Repeats versus Gemcitabine in an Orthotopic Human Pancreatic Cancer Model.”. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 11 (15): 5622-30.

Shaked, Yuval, Francesco Bertolini, Shan Man, Michael S Rogers, Dave Cervi, Thomas Foutz, Kimberley Rawn, et al. 2005. “Genetic Heterogeneity of the Vasculogenic Phenotype Parallels Angiogenesis; Implications for Cellular Surrogate Marker Analysis of Antiangiogenesis.”. Cancer Cell 7 (1): 101-11.

Hochegger, Kathrin, Sara Knight, Christian Hugo, Gert Mayer, Jack Lawler, Tanya N Mayadas, and Alexander R Rosenkranz. 2004. “Role of Thrombospondin-1 in the Autologous Phase of an Accelerated Model of Anti-Glomerular Basement Membrane Glomerulonephritis.”. Nephron. Experimental Nephrology 96 (2).